DADC
ANIX icon

D.A. Davidson & Co’s Anixa Biosciences ANIX Stock Holding History

D.A. Davidson & Co’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Hold
539,272
– – 0.01% 829
2026
Q1 		$1.39M Hold
539,272
– – 0.01% 818
2025
Q4 		$1.68M Sell
539,272
-75,000
-12% -$307K 0.01% 728
2025
Q3 		$2.03M Hold
614,272
– – 0.01% 638
2025
Q2 		$2.03M Hold
614,272
– – 0.01% 608
2025
Q1 		$1.76M Sell
614,272
-56,800
-8% -$162K 0.01% 603
2024
Q4 		$1.56M Hold
671,072
– – 0.01% 639
2024
Q3 		$2.11M Sell
671,072
-65,343
-9% -$201K 0.02% 533
2024
Q2 		$1.63M Buy
+736,415
New +$2.09M 0.01% 588

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

D.A. Davidson & Co's ANIX Position: Q2 2026 in Review

D.A. Davidson & Co held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 539,272 shares worth $1.51M. The position accounts for 0.01% of the portfolio, ranked #829.

D.A. Davidson & Co first reported a position in ANIX in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.11M in Q3 2024. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • D.A. Davidson & Co held 539,272 shares of Anixa Biosciences worth $1.51M as of Q2 2026.
  • D.A. Davidson & Co left its Anixa Biosciences share count unchanged in Q2 2026.
  • Anixa Biosciences made up 0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #829 holding.
  • D.A. Davidson & Co first reported a position in Anixa Biosciences in Q2 2024 and has held it in 9 quarters since.
  • D.A. Davidson & Co's Anixa Biosciences position peaked at $2.11M in Q3 2024.
  • 62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.